CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
14,662
edits
Cancer Therapy Evaluation Program: Difference between revisions
Cancer Therapy Evaluation Program (view source)
Revision as of 23:19, 11 February 2025
, 11 Februaryno edit summary
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
|ProgramType=Program | |ProgramType=Program | ||
|OrgSponsor=National Cancer Institute | |OrgSponsor=National Cancer Institute | ||
|TopOrganization=National Institutes of Health | |||
|CreationLegislation=National Cancer Act of 1971 | |CreationLegislation=National Cancer Act of 1971 | ||
|Purpose=To facilitate the development of new cancer treatments by coordinating and funding clinical trials, managing the supply of investigational agents, and fostering collaborations between researchers, pharmaceutical companies, and academic institutions. The program aims to improve cancer treatment outcomes through innovative research and drug development. | |Purpose=To facilitate the development of new cancer treatments by coordinating and funding clinical trials, managing the supply of investigational agents, and fostering collaborations between researchers, pharmaceutical companies, and academic institutions. The program aims to improve cancer treatment outcomes through innovative research and drug development. | ||